Your browser doesn't support javascript.
loading
Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.
Souza-Fonseca-Guimaraes, Fernando; Blake, Stephen J; Makkouk, Amani; Chester, Cariad; Kohrt, Holbrook E; Smyth, Mark J.
Afiliación
  • Souza-Fonseca-Guimaraes F; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; Molecular Immunology Division, Walter & Elisa Hall Institute of Medical Research, Parkville, VIC, Australia; Faculty of Medicine, Dentistry and Health Sciences, University of Melbou
  • Blake SJ; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute , Herston, QLD, Australia.
  • Makkouk A; Department of Medicine, Division of Oncology, Stanford University , Stanford, CA, USA.
  • Chester C; Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
  • Kohrt HE; Department of Medicine, Division of Oncology, Stanford University , Stanford, CA, USA.
  • Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; School of Medicine, University of Queensland, St Lucia, QLD, Australia.
Oncoimmunology ; 5(7): e1192740, 2016 Jul.
Article en En | MEDLINE | ID: mdl-27622048
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article